Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Advanced Solid Tumor × Injections, Intravenous × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Supratentorial Brain Tumor 1 Advanced Solid Tumor 1

Interventions

spartalizumab 3 anlotinib 2 Therapeutics 2 Injections 2 Cisplatin 2 toripalimab 1 tislelizumab 1 pembrolizumab 1 fludarabine 1 donafenib 1 camrelizumab 1 Pemetrexed 1 Leucovorin 1 Irinotecan 1 Injections, Intravenous 1 Gemcitabine 1 Fluorouracil 1 Cyclophosphamide 1 Carboplatin 1 Capecitabine 1 5'-Nucleotidase 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04719065 2021-11-01

A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Solid Tumor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Unknown

Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡